Mr Enrique Segarra, MD | |
Hospital Auxilio Mutuo (er), Ave Ponce De Leon Parada 37 1/2, Ato Rey, PR 00919 | |
(787) 758-4060 | |
Not Available |
Full Name | Mr Enrique Segarra |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | Hospital Auxilio Mutuo (er), Ato Rey, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912984469 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 5438 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Enrique Segarra, MD Po Box 79111, Carolina, PR 00984-9111 Ph: (787) 791-1087 | Mr Enrique Segarra, MD Hospital Auxilio Mutuo (er), Ave Ponce De Leon Parada 37 1/2, Ato Rey, PR 00919 Ph: (787) 758-4060 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-3117 during a poster session at the American Association for Cancer Research (AACR) 103rd Annual Meeting being held in Chicago, Illinois, March 31 - April 4, 2012, at the McCormick Place Convention Center.
A Johns Hopkins expert panel of health care providers and patients have announced what is, to their knowledge, the nation's first set of operation-specific opioid prescribing guidelines.
The long-standing relationship between a family physician and his/her terminally ill patient is pivotal in the management of depression during palliative care, show Dutch study results.
Guardsman Scientific is pleased to announce that it has been selected as a winner of the annual New England Venture Summit Top Innovator award by youngStartup Ventures.
INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.
› Verified 2 days ago